CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions in Viral Infection and Prevention

Chemokine (C–C motif) ligand 19 (CCL19) is a critical regulator of the induction of T cell activation, immune tolerance, and inflammatory responses during continuous immune surveillance, homeostasis, and development. Migration of CC-chemokine receptor 7 (CCR7)-expressing cells to secondary lymphoid organs is a crucial step in the onset of adaptive immunity, which is initiated by a complex interaction between CCR7 and its cognate ligands. Recent advances in knowledge regarding the response of the CCL19-CCR7 axis to viral infections have elucidated the complex network of interplay among the invading virus, target cells and host immune responses. Viruses use various strategies to evade or delay the cytokine response, gaining additional time to replicate in the host. In this review, we summarize the impacts of CCL19 and CCR7 expression on the regulation of viral pathogenesis with an emphasis on the corresponding signaling pathways and adjuvant mechanisms. We present and discuss the expression, signaling adaptor proteins and effects of CCL19 and CCR7 as these molecules differentially impact different viral infections and viral life cycles in host homeostatic strategies. The underlying mechanisms discussed in this review may assist in the design of novel agents to modulate chemokine activity for viral prevention.

[1]  T-Cell Chemokine , 2020, Definitions.

[2]  S. Zibaee,et al.  Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice. , 2019, Microbial pathogenesis.

[3]  D. Legler,et al.  CCR7 Is Recruited to the Immunological Synapse, Acts as Co-stimulatory Molecule and Drives LFA-1 Clustering for Efficient T Cell Adhesion Through ZAP70 , 2019, Front. Immunol..

[4]  J. Fernandes,et al.  Monocytes of patients with unstable angina express high levels of chemokine and pattern‐recognition receptors , 2019, Cytokine.

[5]  W. Zhiming,et al.  Chemokines and receptors in intestinal B lymphocytes , 2018, Journal of leukocyte biology.

[6]  D. Tscharke,et al.  Tissue‐resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance , 2018, Immunological reviews.

[7]  Yong-Sun Kim,et al.  Prolonged follicular helper T cell responses in ME7 scrapie-infected mice , 2018, Prion.

[8]  F. Rezaei,et al.  The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus. , 2018, Viral immunology.

[9]  Jia Liu,et al.  TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production , 2018, The Journal of Immunology.

[10]  S. H. van der Burg,et al.  Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections , 2018, Front. Immunol..

[11]  H. Wille,et al.  Somatostatin in Alzheimer's disease: A new Role for an Old Player , 2018, Prion.

[12]  I. Ernberg,et al.  Epstein–Barr virus (EBV) provides survival factors to EBV+ diffuse large B‐cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL , 2017, Immunology.

[13]  D. Zawieja,et al.  A Novel Computational Model Predicts Key Regulators of Chemokine Gradient Formation in Lymph Nodes and Site-Specific Roles for CCL19 and ACKR4 , 2017, The Journal of Immunology.

[14]  P. Djurdjevic,et al.  Cytokine profile in chronic hepatitis C: An observation , 2017, Cytokine.

[15]  J. Sidney,et al.  Bolstering the Number and Function of HSV-1–Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease , 2017, The Journal of Immunology.

[16]  J. E. Lima,et al.  Multiple Myeloma Cells Express Key Immunoregulatory Cytokines and Modulate the Monocyte Migratory Response , 2017, Front. Med..

[17]  D. Montefiori,et al.  Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques , 2017, Journal of Virology.

[18]  Angela M. Jarrett,et al.  CCR7 Modulates the Generation of Thymic Regulatory T Cells by Altering the Composition of the Thymic Dendritic Cell Compartment. , 2017, Cell reports.

[19]  R. Thimme,et al.  Overcoming CD8+ T-Cell Exhaustion in Viral Hepatitis: Lessons from the Mouse Model and Clinical Perspectives , 2017, Digestive Diseases.

[20]  S. Lira,et al.  Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis , 2017, Journal of Virology.

[21]  S. Self,et al.  HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Prima , 2017, Journal of Virology.

[22]  M. Ferracin,et al.  Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B , 2017, Nature Medicine.

[23]  B. '. ’t Hart,et al.  Analysis of the cross-talk of Epstein–Barr virus-infected B cells with T cells in the marmoset , 2017, Clinical & translational immunology.

[24]  A. Spivak,et al.  Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo , 2016, Retrovirology.

[25]  M. Rosenkilde,et al.  Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines , 2016, Front. Immunol..

[26]  Ah Ram Lee,et al.  Hepatitis B virus–triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response , 2016, Autophagy.

[27]  A. Uusküla,et al.  T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. , 2016, Viral immunology.

[28]  S. H. van der Burg,et al.  The Breadth of Synthetic Long Peptide Vaccine-Induced CD8+ T Cell Responses Determines the Efficacy against Mouse Cytomegalovirus Infection , 2016, PLoS pathogens.

[29]  Yong-Sun Kim,et al.  Impaired spleen structure and chemokine expression in ME7 scrapie-infected mice. , 2016, Immunobiology.

[30]  M. Churchill,et al.  HIV integration and the establishment of latency in CCL19-treated resting CD4+ T cells require activation of NF-κB , 2016, Retrovirology.

[31]  S. Lewin,et al.  Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro , 2016, PloS one.

[32]  U. Holzgrabe,et al.  Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor* , 2016, The Journal of Biological Chemistry.

[33]  D. Legler,et al.  Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes , 2016, Journal of leukocyte biology.

[34]  R. Solari,et al.  Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery? , 2016, Journal of leukocyte biology.

[35]  R. Thimme,et al.  CD8+ T-Cell Responses in Hepatitis B and C: The (HLA-) A, B, and C of Hepatitis B and C , 2016, Digestive Diseases.

[36]  G. Tiegs,et al.  Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells , 2016, Cellular & Molecular Immunology.

[37]  Rajesh Raju,et al.  Differential ligand-signaling network of CCL19/CCL21-CCR7 system , 2015, Database J. Biol. Databases Curation.

[38]  R. Shattock,et al.  Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9. , 2015, The Journal of general virology.

[39]  Qinxue Hu,et al.  Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge , 2015, The Journal of Immunology.

[40]  Ling-Jun Ho,et al.  Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus , 2015, Journal of cellular and molecular medicine.

[41]  T. Shioda,et al.  The HIV-1 Gp120/CXCR4 Axis Promotes CCR7 Ligand-Dependent CD4 T Cell Migration: CCR7 Homo- and CCR7/CXCR4 Hetero-Oligomer Formation as a Possible Mechanism for Up-Regulation of Functional CCR7 , 2015, PloS one.

[42]  D. Montefiori,et al.  DNA Vaccine Molecular Adjuvants SP-D-BAFF and SP-D-APRIL Enhance Anti-gp120 Immune Response and Increase HIV-1 Neutralizing Antibody Titers , 2015, Journal of Virology.

[43]  W. Cao,et al.  CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[44]  V. Planelles,et al.  Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells. , 2014, Cell reports.

[45]  M. Rosenkilde,et al.  Biased and G Protein-Independent Signaling of Chemokine Receptors , 2014, Front. Immunol..

[46]  Anthony R Cillo,et al.  Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy , 2014, Proceedings of the National Academy of Sciences.

[47]  A. Luster,et al.  Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.

[48]  Y. Jang,et al.  Enhancement of Immune Responses by Co-delivery of CCL19/MIP-3beta Chemokine Plasmid With HCV Core DNA/Protein Immunization , 2014, Hepatitis monthly.

[49]  D. van Baarle,et al.  T Cell Responses to Viral Infections – Opportunities for Peptide Vaccination , 2014, Front. Immunol..

[50]  Wei Zhang,et al.  HSV-2 Vaccine: Current Status and Insight into Factors for Developing an Efficient Vaccine , 2014, Viruses.

[51]  B. Nakstad,et al.  Downregulation of IL7R, CCR7, and TLR4 in the cord blood of children with respiratory syncytial virus disease. , 2013, The Journal of infectious diseases.

[52]  J. Schwarze,et al.  Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of Respiratory Syncytial Virus infection , 2018, Cytokine.

[53]  R. Shattock,et al.  CCL19 and CCL28 Augment Mucosal and Systemic Immune Responses to HIV-1 gp140 by Mobilizing Responsive Immunocytes into Secondary Lymph Nodes and Mucosal Tissue , 2013, The Journal of Immunology.

[54]  S. McColl,et al.  A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system. , 2013, Cytokine & growth factor reviews.

[55]  Thomas Gebhardt,et al.  Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.

[56]  J. Slupsky,et al.  Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF , 2012, Thorax.

[57]  Nupur Bhatnagar,et al.  Loss of CCR7 Expression on CD56bright NK Cells Is Associated with a CD56dimCD16+ NK Cell-Like Phenotype and Correlates with HIV Viral Load , 2012, PloS one.

[58]  S. Frøland,et al.  Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS) , 2012, Clinical and experimental immunology.

[59]  R. Kornbluth,et al.  Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine. , 2012, Vaccine.

[60]  D. Chang,et al.  Immunosuppressive Effects and Mechanisms of Leflunomide in Dengue Virus Infection of Human Dendritic Cells , 2011, Journal of Clinical Immunology.

[61]  R. Rabin,et al.  Low CCR7-Mediated Migration of Human Monocyte Derived Dendritic Cells in Response to Human Respiratory Syncytial Virus and Human Metapneumovirus , 2011, PLoS pathogens.

[62]  A. Osterhaus,et al.  Reciprocal changes of naïve and effector/memory CD8+ T lymphocytes in chronic hepatitis B virus infection. , 2011, Viral immunology.

[63]  Yuriko Tanaka,et al.  Altered antibody production and helper T cell function in mice lacking chemokines CCL19 and CCL21‐Ser , 2010, Microbiology and immunology.

[64]  Percy A. Knolle,et al.  Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.

[65]  Suha M. Saleh,et al.  Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton , 2010, Proceedings of the National Academy of Sciences.

[66]  D. Chang,et al.  Triggering of DC migration by dengue virus stimulation of COX‐2‐dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation , 2009, European journal of immunology.

[67]  G. Klein,et al.  Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein–Barr virus infection , 2009, Immunology.

[68]  Robert J. Lefkowitz,et al.  Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands , 2009, Proceedings of the National Academy of Sciences.

[69]  E. Wherry,et al.  Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients. , 2009, Journal of hepatology.

[70]  A. Coyle,et al.  Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection. , 2009, The Journal of infectious diseases.

[71]  S. Eo,et al.  Genetic co‐transfer of CCR7 ligands enhances immunity and prolongs survival against virulent challenge of pseudorabies virus , 2009, Immunology and cell biology.

[72]  A. Rothman,et al.  Understanding the contribution of cellular immunity to dengue disease pathogenesis , 2008, Immunological reviews.

[73]  M. Groettrup,et al.  Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis , 2008, Journal of Cell Science.

[74]  Antal Rot,et al.  CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.

[75]  J. Mora,et al.  Differentiation and homing of IgA-secreting cells , 2008, Mucosal Immunology.

[76]  Suha M. Saleh,et al.  CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. , 2007, Blood.

[77]  Peter H Seeberger,et al.  Profiling heparin-chemokine interactions using synthetic tools. , 2007, ACS chemical biology.

[78]  Jennifer L. Reed,et al.  Severe Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyte Responses , 2007, The Journal of infectious diseases.

[79]  Pedro Romero,et al.  Four Functionally Distinct Populations of Human Effector-Memory CD8+ T Lymphocytes1 , 2007, The Journal of Immunology.

[80]  T. Onodera,et al.  Chemokines CCL19 and CCL21 promote activation-induced cell death of antigen-responding T cells. , 2007, Blood.

[81]  A. Hartmann,et al.  Cellular Target Genes of Epstein-Barr Virus Nuclear Antigen 2 , 2006, Journal of Virology.

[82]  Graeme Milligan,et al.  The chemokine receptor CCX‐CKR mediates effective scavenging of CCL19 in vitro , 2006, European journal of immunology.

[83]  Guttorm Haraldsen,et al.  Coy decoy with a new ploy: Interceptor controls the levels of homeostatic chemokines , 2006, European journal of immunology.

[84]  J. Connolly,et al.  Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. , 2006, Blood.

[85]  H. Blum,et al.  Expression of the Interleukin-7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection , 2006, Journal of Virology.

[86]  E. Kremmer,et al.  A Somatic Knockout of CBF1 in a Human B-Cell Line Reveals that Induction of CD21 and CCR7 by EBNA-2 Is Strictly CBF1 Dependent and that Downregulation of Immunoglobulin M Is Partially CBF1 Independent , 2005, Journal of Virology.

[87]  H. Schramek,et al.  HIV-1-Induced Migration of Monocyte-Derived Dendritic Cells Is Associated with Differential Activation of MAPK Pathways1 , 2004, The Journal of Immunology.

[88]  A. Thomson,et al.  Migratory responses of murine hepatic myeloid, lymphoid-related, and plasmacytoid dendritic cells to CC chemokines. , 2004, Transplantation.

[89]  A. Cuadrado,et al.  Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. , 2004, Blood.

[90]  T. Blankenstein,et al.  CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. , 2004, Immunity.

[91]  T. Wolff,et al.  CC Chemokine Receptor 7 Expression by Effector/Memory CD4+ T Cells Depends on Antigen Specificity and Tissue Localization during Influenza A Virus Infection , 2004, Journal of Virology.

[92]  T. Kohout,et al.  Differential Desensitization, Receptor Phosphorylation, β-Arrestin Recruitment, and ERK1/2 Activation by the Two Endogenous Ligands for the CC Chemokine Receptor 7* , 2004, Journal of Biological Chemistry.

[93]  U. V. von Andrian,et al.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.

[94]  B. Rouse,et al.  Codelivery of CCR7 Ligands as Molecular Adjuvants Enhances the Protective Immune Response against Herpes Simplex Virus Type 1 , 2003, Journal of Virology.

[95]  B. Rouse,et al.  Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity. , 2003, Virology.

[96]  M. Lipp,et al.  Shaping Up Adaptive Immunity: The Impact of CCR7 and CXCR5 on Lymphocyte Trafficking , 2003, Microcirculation.

[97]  G. Pantaleo,et al.  Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV‐1 and cytomegalovirus infections , 2002, European journal of immunology.

[98]  Y. Yanagawa,et al.  CCL19 induces rapid dendritic extension of murine dendritic cells. , 2002, Blood.

[99]  D. Voehringer,et al.  Cutting Edge: CCR7+ and CCR7− Memory T Cells Do Not Differ in Immediate Effector Cell Function1 , 2002, The Journal of Immunology.

[100]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[101]  M. Baggiolini,et al.  The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC , 2001, European journal of immunology.

[102]  S. Chensue.  Molecular Machinations: Chemokine Signals in Host-Pathogen Interactions , 2001, Clinical Microbiology Reviews.

[103]  R. A. Johnson,et al.  The role of MKK1/2 kinase activity in human cytomegalovirus infection. , 2001, The Journal of general virology.

[104]  P. Murphy.  Viral exploitation and subversion of the immune system through chemokine mimicry , 2001, Nature Immunology.

[105]  C. Murdoch,et al.  Chemokine receptors and their role in inflammation and infectious diseases. , 2000, Blood.

[106]  H. Pircher,et al.  Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity , 1999, European journal of immunology.

[107]  E. Wolf,et al.  CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.

[108]  J. Kim,et al.  IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. , 1999, Journal of immunology.

[109]  O. Yoshie,et al.  Secondary Lymphoid-tissue Chemokine Is a Functional Ligand for the CC Chemokine Receptor CCR7* , 1998, The Journal of Biological Chemistry.

[110]  P. Doherty,et al.  Effector CD4+ and CD8+ T‐cell mechanisms in the control of respiratory virus infections , 1997, Immunological reviews.

[111]  M. Ridanpää,et al.  Molecular Cloning of a Novel Human CC Chemokine Secondary Lymphoid-Tissue Chemokine That Is a Potent Chemoattractant for Lymphocytes and Mapped to Chromosome 9p13* , 1997, The Journal of Biological Chemistry.

[112]  E. Kieff,et al.  Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.

[113]  D. Legler,et al.  CCR 7 Is Recruited to the Immunological Synapse , Acts as Co-stimulatory Molecule and Drives LFA-1 Clustering for Efficient T Cell Adhesion Through ZAP 70 , 2019 .

[114]  R. Shattock,et al.  Inhibition of HIV-1 infection of primary CD 4 + T-cells by gene editing of CCR 5 using adenovirus-delivered CRISPR / Cas 9 , 2015 .

[115]  J. Benovic,et al.  β-arrestins and G protein-coupled receptor trafficking. , 2014, Handbook of experimental pharmacology.

[116]  B. Moser,et al.  Chemokines , 2005, Immunologic research.

[117]  B. Rouse,et al.  Codelivery of CCR 7 Ligands as Molecular Adjuvants Enhances the Protective Immune Response against Herpes Simplex Virus Type 1 , 2003 .

[118]  Antonio Alcami,et al.  Viral mimicry of cytokines, chemokines and their receptors , 2003, Nature Reviews Immunology.

[119]  Y. Yanagawa,et al.  CCL 19 induces rapid dendritic extension of murine dendritic cells , 2002 .

[120]  外川 綱生,et al.  当院におけるMultiple Myeloma Cellsの表面形質の検討 , 2002 .

[121]  E. Huang,et al.  The role of MKK 1 / 2 kinase activity in human cytomegalovirus infection , 2022 .